-
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
Wed, Feb 24 2021
A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.
-
Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
Thu, Feb 04 2021
For patients with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to modify the gut microbiome may help some of these patients respond to the immunotherapy drugs.
-
Some postmenopausal women with breast cancer may forgo chemotherapy
Wed, Dec 09 2020
Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.
-
Study of “exceptional responders” yields clues to cancer and potential treatments
Thu, Nov 19 2020
A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.
